Navigation Links
CytoSorbents to Present at the 2014 Rodman & Renshaw Annual Global Investment Conference

MONMOUTH JUNCTION, N.J., Sept. 3, 2014 /PRNewswire/ -- CytoSorbents Corporation (OTCQB: CTSO) announced that Chief Executive Officer, Dr. Phillip Chan, MD, PhD, will present at the Rodman & Renshaw Annual Global Investment Conference (sponsored by H.C. Wainwright & Co) taking place on September 8-10th in New York City.   CytoSorbents is a critical care immunotherapy company commercializing its CytoSorb® cytokine adsorber to treat patients with life-threatening inflammatory conditions in the intensive care unit in nineteen countries worldwide.

Conference Presentation Details:
Where:  New York Palace Hotel, 455 Madison Avenue, New York, NY 10022
When:  Tuesday, September 9th at 2:05 PM
Room:   Kennedy II Salon (4th Floor)
Conference Website:  Rodman and Renshaw 16th Annual Global Investment Conference

About CytoSorbents Corporation
CytoSorbents Corporation is a critical care focused immunotherapy company using blood purification to modulate inflammation -- with the goal of preventing or treating multiple organ failure in life-threatening illnesses. Organ failure is the cause of nearly half of all deaths in the intensive care unit, with little to improve clinical outcome. CytoSorb®, the Company's flagship product, is approved in the European Union as a safe and effective extracorporeal cytokine adsorber, designed to reduce the "cytokine storm" that could otherwise cause massive inflammation, organ failure and death in common critical illnesses such as sepsis, burn injury, trauma, lung injury, and pancreatitis. These are conditions where the risk of death is extremely high, yet no effective treatments exist. CytoSorb® is also being used during and after cardiac surgery to try to remove inflammatory mediators, such as cytokines and free hemoglobin, which can lead to post-operative complications, including multiple organ failure.

CytoSorbents' purification technologies are based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbents has numerous products under development based upon this unique blood purification technology, protected by 32 issued US patents and multiple applications pending, including HemoDefend™, ContrastSorb, DrugSorb, and others. Additional information is available for download on the Company's website:

Forward-Looking Statements
This press release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. Forward-looking statements in this press release are not promises or guarantees and are subject to risks and uncertainties that could cause our actual results to differ materially from those anticipated. These statements are based on management's current expectations and assumptions and are naturally subject to uncertainty and changes in circumstances. We caution you not to place undue reliance upon any such forward-looking statements. Actual results may differ materially from those expressed or implied by the statements herein. Risk factors are detailed in the Company's Form 10-K filed with the SEC on March 31, 2014, which is available at

Logo -

SOURCE CytoSorbents Corporation
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. CytoSorbents Records Another Solid Quarter of Growth in Q2 2014
2. CytoSorbents Expands Distribution to Taiwan with Hemoscien Corporation
3. CytoSorbents Receives Approximately $400,000 in Non-Dilutive Capital from the Sale of Net Operating Loss Carryovers
4. Inovio to Present at Upcoming Investor Conferences
5. Isis Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference
6. RXi Pharmaceuticals to Present at the Rodman & Renshaw 16th Annual Global Investment Conference
7. Relmada Therapeutics to Present at the 16th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th, 2014
8. Avanir Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference
9. Abaxis, Inc. to Present at the Morgan Stanley Global Healthcare Conference
10. Volcano Corporation Presentation At Morgan Stanley Conference To Be Webcast
11. Hologic to Present at the Morgan Stanley Global Healthcare Conference
Post Your Comments:
(Date:11/24/2015)... FRANCISCO , Nov. 24, 2015  Thanks to ... Dignity Health St. Mary,s Medical Center,s Sister Diane Grassilli ... breast imaging capabilities in San Francisco ... an anonymous friend, stepped forward with a gift of ... for Breast Digital Mammography with Tomosynthesis and Whole Breast ...
(Date:11/24/2015)... Colo. , Nov. 24, 2015  Array ... that its Chief Executive Officer, Ron Squarer ... Healthcare Conference in New York.  The public is ... webcast on the Array BioPharma website.Event:Piper Jaffray Annual ... , Wednesday, December 2, 2015Time:1:30 p.m. Eastern Time ...
(Date:11/24/2015)... HOUSTON, TX and VANCOUVER, Nov. 24, 2015 /PRNewswire/ ... EPI; NASDAQ: EPIX ) announced today that the ... clinical study of EPI-506 as a treatment for metastatic ... States and Canada.  --> ... --> In the Phase 1/2 clinical trial, ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... “While riding the bus, I ... Bronx, N.Y. “I thought there had to be a convenient and comfortable way to ... The PROTECTOR enables disabled individuals to safely travel during cold or inclement weather. In ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... philanthropic seniors, is resulting in a way for homeless people to have a ... have launched a new initiative whereby they are repurposing plastic bags into sleeping ...
(Date:11/25/2015)... ... November 25, 2015 , ... Since its launch in 2012, ... adult stem cell therapies to patients with chronic degenerative medical conditions. Now, the ... Registered Trademark (RTM). , Organizations are required to hold a registered trademark in ...
(Date:11/24/2015)... ... November 25, 2015 , ... Genesis Chiropractic Software ... software creates an agreement between the practice owner and the patient that automatically ... notification, and projections. Click here to learn more. , ...
Breaking Medicine News(10 mins):